Cytokinetics (CYTK) Misses Q3 EPS by 98c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $86.49 +1.44%
EPS Growth %: -46.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
CRMT, More
EPS Growth %: -46.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($2.55), $0.98 worse than the analyst estimate of ($1.57). Revenue for the quarter came in at $1.93 million versus the consensus estimate of $6.05 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Sodexo (SW:FP) (SDXAY) PT Raised to EUR53 at Deutsche Bank
- Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
